Severe hypertension after initiation of rifapentine/isoniazid for latent tuberculosis in renal transplant candidates
Authors:
- 29 December 2016
- journal article
- Published by Frontiers Media SA in Transplant International
- Vol. 30 (1) , 108-109
Abstract
Latent tuberculosis infection (LTBI) is not uncommon among renal transplant candidates (RTC) [1]. Rifapentine/isoniazid (RPT/INH) administered for 12 weeks is one of the first line treatments for LTBI [1] and we have recently showed that it is associated with higher completion rates than INH monotherapy for 9 months [2].Keywords
This publication has 6 references indexed in Scilit:
- Treatment of Acute Antibody-Mediated Renal Allograft Rejection With CyclophosphamideTransplantation, 2017
- Increased postdialysis systolic blood pressure is associated with extracellular overhydration in hemodialysis outpatientsKidney International, 2015
- Mycobacterium tuberculosis Infections in Solid Organ TransplantationAmerican Journal of Transplantation, 2013
- Update on rifampin, rifabutin, and rifapentine drug interactionsCurrent Medical Research and Opinion, 2012
- The cardiovascular effects of erythropoietinCardiovascular Research, 2003
- Sympathetic Overactivity in Patients with Chronic Renal FailureNew England Journal of Medicine, 1992